Embla Medical hf (Embla Medical hf) Interest Expense : $-19.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Embla Medical hf's interest expense for the three months ended in Mar. 2024 was $ -6.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-19.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Embla Medical hf's Operating Income for the three months ended in Mar. 2024 was $ 15.2 Mil. Embla Medical hf's Interest Expense for the three months ended in Mar. 2024 was $ -6.0 Mil. Embla Medical hf's Interest Coverage for the quarter that ended in Mar. 2024 was 2.52. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embla Medical hf Interest Expense Historical Data

The historical data trend for Embla Medical hf's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Interest Expense Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-8.33

-9.61

-9.80

-11.20

-17.96

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-4.44	-6.79	-4.50	-2.24	-6.02

Embla Medical hf Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.5 Mil.

Embla Medical hf (OTCPK:OSSUY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Embla Medical hf's Interest Expense for the three months ended in Mar. 2024 was $-6.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was $15.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $475.6 Mil.

Embla Medical hf's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	15.183	/	-6.02
	=	2.52

The higher the ratio, the stronger the company's financial strength is.

Embla Medical hf (Embla Medical hf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSR:Denmark

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.